Jam

WuXi Biologics (2269.HK) announced SBTi approval of its near-term and net-zero GHG emissions reduction targets, aligning with 1.5°C pathways and committing to net-zero across its value chain by 2050. As a leading Green CRDMO, WuXi Biologics implements a comprehensive strategy, engaging suppliers to reduce its environmental footprint. CEO Dr. Chris Chen views this as a catalyst for further action and delivering ESG excellence. The company holds MSCI AAA Rating, EcoVadis Platinum Medal, and DJSI listing.

8×8, Inc. has extended its partnership with Southampton FC, continuing as an official partner for Men’s and Women’s First Teams through the 2025/26 season. 8×8’s cloud-based technology is integral to the club’s operations, enhancing matchday experiences and fan engagement through streamlined communications. The partnership focuses on fostering deeper connections with supporters via personalized interactions and timely updates. The renewed agreement includes increased brand visibility and collaborative community outreach programs, leveraging 8×8’s unified platform to elevate fan experiences and operational efficiency.

CMB.TECH (CMBT) reported mixed Q2 2025 results. While revenue increased to $387.8 million, the company posted a net loss of $7.6 million, a stark contrast to the $184.4 million profit in Q2 2024. EBITDA also declined to $224.1 million. The merger with Golden Ocean was completed, creating a 250-vessel fleet. CMB.TECH declared an interim dividend of $0.05 USD and maintains a strong contract backlog of $2.93 billion. Vessel sales generated significant capital gains. Legal challenges from Golden Ocean shareholders remain.

Cognition Therapeutics (CGTX) announced a $30 million direct offering of 14.7 million common shares to two new institutional investors. Closing is expected around August 29, 2025. Proceeds will fund Phase 3 program preparation for zervimesine in neurodegenerative disorders, working capital, and general corporate purposes. Titan Partners Group acted as the sole placement agent. This secures funding to advance zervimesine to Phase 3 trials, however, the offering causes share dilution.

SK hynix has begun shipping mobile DRAM featuring industry-first High-K EMC, significantly improving thermal management. This innovation boosts thermal conductivity by 3.5x and reduces thermal resistance by 47%, mitigating heat issues in on-device AI applications, where rising data transfer rates generate considerable heat. The breakthrough is achieved by incorporating Alumina into Silica-based EMC. SK hynix aims to lead in next-generation mobile DRAM through continued material innovation, enhancing performance and extending device lifespan.

General Enterprise Ventures (GEVI) announced a 1-for-6 reverse stock split, effective August 27, 2025, reducing outstanding shares to approximately 14.6 million. The stock will trade as GEVID temporarily before reverting to GEVI. This strategic move aims to meet national securities exchange listing requirements and attract institutional investors. The split won’t affect percentage ownership; fractional shares will be rounded up. The company, through its subsidiary Mighty Fire Breaker, seeks growth in wildfire prevention technology.

Toll Brothers is offering a final opportunity to purchase luxury townhomes at its Hilltop community in Reno, Nevada. Located next to Lakeridge Golf Course, these move-in ready, three-story residences range from 2,636 to over 3,010 square feet, with prices starting in the mid-$700,000s. Each home features 3 bedrooms, multiple baths, and a 2-car garage, plus finished basements, covered patios, and decks ideal for full-time living or a low-maintenance lifestyle.

CNH Industrial (CNHI) has priced a €500 million offering of 3.875% notes due September 3, 2035, at 98.906% of the principal amount. The proceeds will be used for general corporate purposes, including debt repayment. Offered exclusively outside the U.S. to non-U.S. institutional investors, the notes will be listed on the Euronext Dublin Global Exchange Market. The transaction, expected to close September 3, 2025, aims to optimize CNH’s debt maturity profile and reflects a proactive capital management strategy.

Seven Arts Entertainment Inc. (SAPX) has formed a joint venture with Hanger Ink, aiming to leverage Hanger’s production capabilities in marketing materials, set design, and branded merchandise. The venture is projected to generate $5-8 million in revenue over the next 18 months. SAPX also secured a 90-day window for a potential acquisition of Hanger Ink and is undergoing extended due diligence. The partnership seeks to capitalize on cross-promotion and Hanger’s industry relationships.

Renovaro Inc. (NASDAQ:RENB) rebranded as Lunai Bioworks, focusing on AI-powered biodefense, drug discovery, and advanced diagnostics. This follows its merger with BioSymetrics, bringing partnerships with Janssen, Pfizer, Merck, and others. Lunai’s platform uses multimodal AI for real-time biological signal analysis, enabling early detection, patient stratification, and therapeutic targeting. The stock will continue trading under the RENB ticker. CEO David Weinstein emphasizes the company’s commitment to addressing global health and security challenges with AI-driven solutions.